Center for Medicine in the Public Interest
CMPI Board of Directors
The CMPI Board of Directors is comprised of some of the nation's leaders in academic medical research, clinical practice, health care delivery, patient advocacy, innovation leadership and science reporting. The board will be involved in helping CMPI reaching a broader group of stakeholders in their respective communities and in shaping CMPI programs in the future.
- Principal, Atlas Venture
- Publisher, Scientific American
- Fred Goodwin, M.D.
- Professor of Psychiatry, The George Washington University Medical Center
- Vice President, Policy and External Affairs at The Children's Health Fund
- Suzanne Pattee, J.D.
- Vice president, Public Policy and Patient Affairs for the Cystic Fibrosis Foundation
- Lecturer, Wharton School, the Law School and the School of Engineering and Applied Science of the University of Pennsylvania
- Mark Thornton, M.D., Ph.D.
- Chairman and President, Sarcoma Foundation of America
- Michael Weber, M.D.
- Associate Dean and Professor of Medicine, SUNY Downstate College of Medicine, Brooklyn, New York
- Raymond Woosley, M.D., Ph.D.
- President and CEO, C-Path Institute
CMPI Advisory Board
- President and CEO, The Heartland Institute, Chicago, IL
- Senior Fellow, American Enterprise Institute, Washington, D.C.
- Joseph A. DiMasi, Ph.D.
- Director of Economic Analysis, Tufts Center for the Study of Drug Development, Tufts University, Boston, MA
- Director, Stockholm Network, London, England
- Executive Director, Coalition for Healthcare Communication
- General Counsel, Competitive Enterprise Institute
- Dr. Merrill Mathews, Jr.
- Resident Scholar, Institute for Policy Innovation
- Director, Council for Affordable Health Insurance
- Attorney, Mayer, Brown, Rowe & Maw LLP, Washington, D.C.
- Director, International Policy Network, London
- Professor, The Harris School, Chicago, IL
- Senior Fellow at the Centre for the New Europe, Brussels, Belgium
- CEO, University of North Carolina Health Care System
- Ellen V. Sigal, Ph.D.
- Founder and Chairperson, Friends of Cancer Research
- Samuel C. Silverstein, M.D.
- John C. Dalton Professor and Chairman, Department of Physiology and Cellular Biophysics, Columbia University
- Professor of Medicine, College of Physicians and Surgeons, Columbia University
- Philip Stieg, M.D.
- Professor and Chairman, Department of Neurological Surgery, Weill Medical College
- Neurosurgeon-in-Chief, New York-Presbyterian Hospital
- Former Chief Counsel of the Food and Drug Administration (FDA)
- Partner in the Washington, New York Offices of Sidley Austin Brown & Wood
- President, The Galen Institute
- Senior Fellow in Economics, Pacific Research Institute
- Adjunct scholar, Cato Institute, Claremont Institute
